{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:05:00Z","timestamp":1781921100961,"version":"3.54.5"},"reference-count":24,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.2967\/jnumed.120.258574","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T23:00:17Z","timestamp":1612566017000},"page":"1422-1429","source":"Crossref","is-referenced-by-count":40,"title":["Matched-Pair Comparison of <sup>18<\/sup>F-DCFPyL PET\/CT and <sup>18<\/sup>F-PSMA-1007 PET\/CT in 240 Prostate Cancer Patients: Interreader Agreement and Lesion Detection Rate of Suspected Lesions"],"prefix":"10.2967","volume":"62","author":[{"given":"Maurits","family":"Wondergem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friso M.","family":"van der Zant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter A.M.","family":"Broos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco J.J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2022032307250584000_62.10.1422.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2525-5"},{"key":"2022032307250584000_62.10.1422.2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/RLU.0000000000001197","article-title":"68Ga-PSMA-PET\/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET\/CT","volume":"41","author":"Bluemel","year":"2016","journal-title":"Clin Nucl Med."},{"key":"2022032307250584000_62.10.1422.3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00345-018-2182-1","article-title":"68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review","volume":"36","author":"Corfield","year":"2018","journal-title":"World J Urol."},{"key":"2022032307250584000_62.10.1422.4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/JU.0000000000000531","article-title":"Prospective validation of gallium-68 PSMA-PET\/CT in primary staging of prostate cancer patients","volume":"203","author":"van Kalmthout","year":"2020","journal-title":"J Urol."},{"key":"2022032307250584000_62.10.1422.5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.juro.2017.07.070","article-title":"Prostate specific membrane antigen targeted 18F-DCFPyL positron emission tomography\/computerized tomography for the preoperative staging of high risk prostate cancer: results of a prospective, phase II, single center study","volume":"199","author":"Gorin","year":"2018","journal-title":"J Urol."},{"key":"2022032307250584000_62.10.1422.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.197160"},{"key":"2022032307250584000_62.10.1422.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.201749"},{"key":"2022032307250584000_62.10.1422.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4853"},{"key":"2022032307250584000_62.10.1422.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.186767"},{"key":"2022032307250584000_62.10.1422.10","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-015-0850-8"},{"key":"2022032307250584000_62.10.1422.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2298-2"},{"key":"2022032307250584000_62.10.1422.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.156133"},{"key":"2022032307250584000_62.10.1422.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161299"},{"key":"2022032307250584000_62.10.1422.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3419-0"},{"key":"2022032307250584000_62.10.1422.15","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2967\/jnumed.117.204669","article-title":"Intraindividual comparison of 18F-PSMA-1007 and 18F-DCFPyL PET\/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: a pilot study","volume":"59","author":"Giesel","year":"2018","journal-title":"J Nucl Med."},{"key":"2022032307250584000_62.10.1422.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3573-4"},{"key":"2022032307250584000_62.10.1422.17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.eururo.2017.10.027","article-title":"PSMA-RADS version 1.0: a step towards standardizing the interpretation and reporting of PSMA-targeted PET imaging studies","volume":"73","author":"Rowe","year":"2018","journal-title":"Eur Urol."},{"key":"2022032307250584000_62.10.1422.18","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2022032307250584000_62.10.1422.19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00259-019-04385-6","article-title":"Early lesion detection with 18F-DCFPyL PET\/CT in 248 patients with biochemically recurrent prostate cancer","volume":"46","author":"Wondergem","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022032307250584000_62.10.1422.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.234898"},{"key":"2022032307250584000_62.10.1422.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.229187"},{"key":"2022032307250584000_62.10.1422.22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00345-017-2096-3","article-title":"99mTc-HDP bone scintigraphy and 18F-sodiumfluoride PET\/CT in primary staging of patients with prostate cancer","volume":"36","author":"Wondergem","year":"2018","journal-title":"World J Urol."},{"key":"2022032307250584000_62.10.1422.23","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00259-017-3780-7","article-title":"Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging","volume":"44","author":"Sheikhbahaei","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022032307250584000_62.10.1422.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.181768"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.258574","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T14:27:19Z","timestamp":1648045639000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.258574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,1]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.2967\/jnumed.120.258574"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.258574","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]}}}